Deutsche Bank AG, Frankfurt Post Stabilisation Notice - Urenco Finance N.V. (2519R)
05 July 2022 - 12:10AM
UK Regulatory
TIDM44ZP
RNS Number : 2519R
Deutsche Bank AG, Frankfurt
04 July 2022
4(th) July 2022
Not for distribution, directly or indirectly, in or into the
United States or
any jurisdiction in which such distribution would be
unlawful.
Urenco Finance N.V.
(the Issuer)
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 1(st)
June 2022 , Deutsche Bank AG, Frankfurt (contact: Debt Syndicate,
Phone No. +44 207 547 6885) hereby gives notice that no
stabilisation (within the meaning of Article 3.2(d) of the Market
Abuse Regulation (EU/596/2014)) , and also as it forms part of UK
domestic law by virtue of the European Union (Withdrawal) Act 2018
was undertaken by the Stabilisation Manager(s) named below in
relation to the offer of the following securities.
The Securities:
Issuer: Urenco Finance N.V.
Guarantor (if any): Urenco Limited
Urenco UK Limited
Urenco Nederland B.V.
Urenco Deutschland GmbH
Louisiana Energy Services, LLC
Aggregate nominal amount: EUR 500m
Description: Urenco, EUR 500M, 3.25% Fxd, 10y
ISIN Code: XS2489138789
Issue/reoffer price: 99.790%
Spread over benchmark: DBR 0% due 15 February 2032 + 215.3
bps
Stabilisation:
Stabilising Manager(s): Barclays, BNP Paribas, Credit Agricole
CIB, Deutsche Bank
This announcement is for information purposes only and does not
constitute an invitation or offer to underwrite, subscribe for or
otherwise acquire or dispose of any securities of the Issuer in any
jurisdiction.
This announcement is not an offer of securities for sale into
the United States. The securities referred to above have not been,
and will not be, registered under the United States Securities Act
of 1933 and may not be offered or sold in the United States absent
registration or an exemption from registration. There has not been
and will not be a public offer of the securities in the United
States.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
STABSGDRRGGDGDS
(END) Dow Jones Newswires
July 04, 2022 10:10 ET (14:10 GMT)
Urenco 24 (LSE:44ZP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Urenco 24 (LSE:44ZP)
Historical Stock Chart
From Dec 2023 to Dec 2024